HemaSphere (Aug 2023)

P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP

  • Theodoros Vassilakopoulos,
  • B Ferhanoglu,
  • Na Horowitz,
  • J Apostolidis,
  • Z Mellios,
  • Alexia Piperidou,
  • L Kaynar,
  • M Zektser,
  • A Giotasmater,
  • Dei Hospital,
  • Msida Malta,
  • A Symeonidis,
  • C Kalpadakis,
  • A Agathocleous,
  • Om Akay,
  • A Sayyed,
  • Sc Atalar,
  • E Katodritou,
  • T Leonidopoulou,
  • Sg Papageorgiou,
  • T. Tadmor,
  • O Gutwein,
  • S Karakatsanis,
  • C Ganzel,
  • G. Karianakis,
  • G. Y. Isenberg,
  • G Gainaru,
  • E. Vrakidou,
  • M Palassopoulou,
  • M Ozgur,
  • Marina Siakantaris,
  • S Paydas,
  • P Tsirigotis,
  • M Tsirogianni,
  • E Hatzimichael,
  • Tf Tugular,
  • Jv Assimakopoulos,
  • L Ligdi,
  • A Liaskas,
  • Maria Aikaterini Lefaki,
  • P Labropoulou,
  • A Kopsaftopoulou,
  • E Verrou,
  • M Kanellias,
  • P Zikos,
  • A Koumarianou,
  • A Gafter-Gvili,
  • M Bouzani,
  • Mk Angelopoulou,
  • T Karmiris,
  • R Gurion

DOI
https://doi.org/10.1097/01.HS9.0000971608.25225.83
Journal volume & issue
Vol. 7
p. e2522583

Abstract

Read online

No abstracts available.